Asciminib Impurity 9 | CAS 1492953-73-7 - Request Quote
Asciminib Impurity 9
| SZ CAT No: | SZ-A157013 |
| CAS No | 1492953-73-7 |
| Mol.F. | C20H18F3N5O3 |
| Mol.Wt. | 433.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Asciminib Impurity 9 is chemically (S)-6-(3-Hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-3-yl)-N-(4-(trifluoromethoxy)phenyl)nicotinamide. Asciminib Impurity 9 is supplied with detailed characterization data compliant with regulatory guideline. Asciminib Impurity 9 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Asciminib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1492953-73-7
Purchase 1492953-73-7
Order 1492953-73-7
Enquire 1492953-73-7
price of 1492953-73-7
1492953-73-7 Supplier
1492953-73-7 Manufacturer
1492953-73-7 Exporter
buy high quality Asciminib Impurity 9
Purchase Asciminib Impurity 9
Asciminib Impurity 9 suppliers
Asciminib Impurity 9 manufacturers
Asciminib Impurity 9 price
Order Asciminib Impurity 9
Enquire Asciminib Impurity 9
Asciminib Impurity 9 cost
Asciminib Impurity 9 Supplier
Asciminib Impurity 9 Distributor
Asciminib Impurity 9 for Method Validation
Asciminib Reference Standard
Asciminib Impurity 9 for ANDA Filing
Asciminib Impurity 9 for Forced Degradation Studies
Asciminib Impurity 9 Identification Standards
Asciminib Impurity 9 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.